Related references
Note: Only part of the references are listed.Prevalence, correlates and management of type 2 diabetes mellitus in Lebanon: Findings from a national population-based study
Christy Costanian et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Global estimates of diabetes prevalence for 2013 and projections for 2035
L. Guariguata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Plasma Homocysteine level and its clinical correlation with type 2 diabetes mellitus and its complications
Satyendra Kumar Sonkar et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2014)
Multivariate epidemiologic analysis of type 2 diabetes mellitus risks in the Lebanese population
Michella Ghassibe-Sabbagh et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach
Tao Huang et al.
BMC GENOMICS (2013)
Methylenetetrahydrofolate Reductase Gene Polymorphism and Risk of Type 2 Diabetes Mellitus
Jian-Hong Zhong et al.
PLOS ONE (2013)
Dietary Factors and Type 2 Diabetes in the Middle East: What Is the Evidence for an Association?-A Systematic Review
Lena Al-Khudairy et al.
NUTRIENTS (2013)
Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk
Michella Ghassibe-Sabbagh et al.
ATHEROSCLEROSIS (2012)
Association of the C677T Polymorphism in the Human Methylenetetrahydrofolate Reductase (MTHFR) Gene with the Genetic Predisposition for Type 2 Diabetes Mellitus in a Moroccan Population
Houda Benrahma et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan
S. M. J. Scullion et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study
Giuseppina Tiziana Russo et al.
ACTA DIABETOLOGICA (2011)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability Additional Findings From the HOPE 2 Trial
Gustavo Saposnik et al.
STROKE (2009)
Menopause modulates homocysteine levels in diabetic and non-diabetic women
G. T. Russo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic β-cell glucose metabolism and insulin secretion
S. Patterson et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Reduced serum homocysteine levels in type 2 diabetes
A Mazza et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2005)
Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors
E Diakoumopoulou et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2005)
Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus
M Soinio et al.
ANNALS OF INTERNAL MEDICINE (2004)
Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients
JH Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes
HC Looker et al.
DIABETOLOGIA (2003)
MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation
M Maeda et al.
DIABETES CARE (2003)
Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus
MT Agulló-Ortuño et al.
CLINICA CHIMICA ACTA (2002)
The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-β-synthase:: studies in hepatocytes
A Dicker-Brown et al.
ATHEROSCLEROSIS (2001)
A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk
KJA Lievers et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Fasting plasma homocysteine levels in the insulin resistance syndrome - The Framingham Offspring Study
JB Meigs et al.
DIABETES CARE (2001)
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes
M Emoto et al.
DIABETES CARE (2001)
Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease - Evidence that all three MTHFR C677T genotypes confer different levels of risk
LAJ Kluijtmans et al.
EUROPEAN HEART JOURNAL (2001)
Hyperhomocysteinemia in type 2 diabetes - Relationship to macroangiopathy, nephropathy, and insulin resistance
M Buysschaert et al.
DIABETES CARE (2000)
Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes - 5-year follow-up of the Hoorn study
EK Hoogeveen et al.
CIRCULATION (2000)
Share Paper
